Dendritic Lipopeptide Nanovaccines Orchestrate Multi-Pattern Recognition Receptors Activation and Potentiate...

Area of Science:

• Immunology
• Nanotechnology
• Materials Science

Background:

• Effective vaccines require precise spatial and temporal control of antigen and adjuvant delivery.
• Current vaccine strategies often struggle to elicit durable and potent immune responses.

Purpose of the Study:

• To develop a self-assembling nanovaccine platform based on dendritic lipopeptides (DLPs).
• To integrate antigen delivery and immune stimulation within a structurally defined nanostructure.
• To evaluate the efficacy of these nanovaccines in preclinical cancer models.

Main Methods:

• Constructed DLPs by conjugating lipid tails to dendritic scaffolds, optimizing amphiphilic properties.
• Engineered nanovaccines by co-assembling DLPs with lipidated antigens and TLR agonists.
• Assessed nanovaccine efficacy in murine melanoma and colorectal tumor models, measuring cytotoxic T lymphocyte responses and tumor regression.

Main Results:

• Developed DLPs with enhanced Toll-like receptor (TLR) 2/4 agonist activity, facilitating antigen uptake and cross-presentation by antigen-presenting cells (APCs).
• Created nanoscale vaccines inducing synergistic multi-pattern recognition receptor (PRR) activation.
• Achieved up to 40% enhancement in antigen-specific killing and significant tumor regression in preclinical models.

Conclusions:

• The modular DLP nanoplatform mimics pathogen-like immunity for enhanced vaccine efficacy.
• This chemically defined platform offers a rational strategy for engineering potent and translatable minimalist cancer vaccines.